These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
565 related articles for article (PubMed ID: 16295759)
1. [Expression of proliferation marker Ki 67 in chronic lymphocytic leukemia]. Diop S; Letestu R; Orsolani D; Leboeuf Y; Le Tutour P; Thiam D; Diakhate L; Valensi F Dakar Med; 2005; 50(2):65-8. PubMed ID: 16295759 [TBL] [Abstract][Full Text] [Related]
2. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment. Kusenda J; Babusíková O Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418 [TBL] [Abstract][Full Text] [Related]
3. Leukemic phase of B-cell lymphomas mimicking chronic lymphocytic leukemia and variants at presentation. Nelson BP; Variakojis D; Peterson LC Mod Pathol; 2002 Nov; 15(11):1111-20. PubMed ID: 12429788 [TBL] [Abstract][Full Text] [Related]
4. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia. Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951 [TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody Ki-67 identifies B and T cells in cycle in chronic lymphocytic leukemia: correlation with disease activity. Cordone I; Matutes E; Catovsky D Leukemia; 1992 Sep; 6(9):902-6. PubMed ID: 1387694 [TBL] [Abstract][Full Text] [Related]
6. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases. Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002 [TBL] [Abstract][Full Text] [Related]
7. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray. Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079 [TBL] [Abstract][Full Text] [Related]
8. Quantitative expression of CD23 and its ligand CD21 in chronic lymphocytic leukemia. Lopez-Matas M; Rodriguez-Justo M; Morilla R; Catovsky D; Matutes E Haematologica; 2000 Nov; 85(11):1140-5. PubMed ID: 11064465 [TBL] [Abstract][Full Text] [Related]
10. [Relevance of cytological and immunophenotypical analysis for the diagnosis of B-cell chronic lymphocytic leukaemia]. Guillaume N; Alimardani G; Capiod JC; Claisse JF Ann Biol Clin (Paris); 2002; 60(6):673-81. PubMed ID: 12446231 [TBL] [Abstract][Full Text] [Related]
11. Phenotypic heterogeneity of B cells in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. Kampalath B; Barcos MP; Stewart C Am J Clin Pathol; 2003 Jun; 119(6):824-32. PubMed ID: 12817430 [TBL] [Abstract][Full Text] [Related]
13. Chromosome aberrations evaluated by comparative genomic hybridization in B-cell chronic lymphocytic leukemia: correlation with CD38 expression. Ottaggio L; Viaggi S; Zunino A; Zupo S; Rossi E; Spriano M; Abbondandolo A; Ferrarini M Haematologica; 2003 Jul; 88(7):769-77. PubMed ID: 12857555 [TBL] [Abstract][Full Text] [Related]
14. Mitogen induced activation, proliferation and surface antigen expression patterns in unmutated and hypermutated chronic lymphocytic leukemia cells. Vilpo J; Tobin G; Hulkkonen J; Hurme M; Thunberg U; Sundström C; Vilpo L; Rosenquist R Eur J Haematol; 2005 Jul; 75(1):34-40. PubMed ID: 15946308 [TBL] [Abstract][Full Text] [Related]
15. Monoclonal expansion of immunoglobulin not-secreting CD5+ CD11c+ CD38+ B-cells in a rare case of chronic lymphoplasmacytoid leukaemia. Grande M; Lucivero G; Gambatesa V; Schiraldi O; Bonomo L Nouv Rev Fr Hematol (1978); 1994 Jun; 36(3):235-40. PubMed ID: 7971244 [TBL] [Abstract][Full Text] [Related]
16. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression. Hojjat Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Shamsian Khoramabadi A; Rabbani H; Shokri F Iran J Immunol; 2008 Mar; 5(1):25-35. PubMed ID: 18319522 [TBL] [Abstract][Full Text] [Related]
17. Cytoplasmic and surface membrane phenotypic markers in cells of B cell chronic lymphocytic leukemia. Koníková E; Babusíková O; Mesárosová A; Kusenda J; Glasová M Neoplasma; 1994; 41(2):69-74. PubMed ID: 8208317 [TBL] [Abstract][Full Text] [Related]
18. CD5-negative, CD10-negative small B-cell leukemia: variant of chronic lymphocytic leukemia or a distinct entity? Sheikh SS; Kallakury BV; Al-Kuraya KA; Meck J; Hartmann DP; Bagg A Am J Hematol; 2002 Dec; 71(4):306-10. PubMed ID: 12447961 [TBL] [Abstract][Full Text] [Related]
19. Purine metabolism enzymes and immunological phenotype in chronic B-cell malignancies: chronic lymphocytic leukemia, prolymphocytic leukemia and hairy cell leukemia. Babusíková O; Hrivnáková A; Klobusická M; Mesárosová A; Ujházy P Neoplasma; 1990; 37(6):693-701. PubMed ID: 2125699 [TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of ZAP-70 expression and Ig VH mutational status in B-cell chronic lymphocytic leukemia. Muñoz L; Lasa A; Carricondo MT; Hernández C; Ubeda J; Nomdedéu JF Cytometry B Clin Cytom; 2007 Mar; 72(2):96-102. PubMed ID: 17051526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]